Remote Ischemic Conditioning for High Altitude Polycythemia in High-Altitude Immigrant Populations
NCT: NCT07562464 · NOT_YET_RECRUITING
Brief Summary
This study is a multicenter, prospective, randomized, open-label, parallel-controlled clinical trial. The participants are adult patients with high-altitude polycythemia who have been long-term residents (for \>6 months) in regions at an altitude of ≥2500 meters. Participants are randomly assigned to one of two groups: a conventional medication group and a remote ischemic conditioning (RIC) intervention group. The study aims to evaluate the effectiveness of a standardized 90-day RIC intervention, as an add-on to conventional medication, in managing high-altitude polycythemia.
Frequently Asked Questions
What is Remote Ischemic Conditioning for High Altitude Polycythemia in High-Altitude Immigrant Populations?
Remote Ischemic Conditioning for High Altitude Polycythemia in High-Altitude Immigrant Populations is a clinical trial registered under NCT07562464. Current status: NOT_YET_RECRUITING.
What is the status of NCT07562464?
The current status of NCT07562464 (Remote Ischemic Conditioning for High Altitude Polycythemia in High-Altitude Immigrant Populations) is: NOT_YET_RECRUITING.
When did Remote Ischemic Conditioning for High Altitude Polycythemia in High-Altitude Immigrant Populations start?
Remote Ischemic Conditioning for High Altitude Polycythemia in High-Altitude Immigrant Populations started on 2026-05-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.